MedTrace Logo

Bonipar for Acute and Chronic Musculoskeletal Pain

NCT03471507 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 164

Last updated 2023-09-18

Study results available
· View outcomes & findings →

Summary

This study is a non-inferiority study comparing efficacy and onset of action between the herbal extracts topical solution, Bonipar, and diclofenac sodium topical solution, diclofenac topical solution 1.5%.

Conditions

Interventions

DRUG

Bonipar

Apply 2 pumps 2 times a day to be applied topically on the affected area during a two week treatment period.

DRUG

Diclofenac sodium topical solution 1.5%

Apply 2 pumps 2 times a day to be applied topically on the affected area during a two week treatment period.

Sponsors & Collaborators

  • Winston Parris, MD

    lead OTHER

Principal Investigators

  • Lance Roy, MD · Duke University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-15
Primary Completion
2022-09-22
Completion
2022-09-22
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03471507 on ClinicalTrials.gov